Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Endocrine. 2017 Dec 4;59(1):143–150. doi: 10.1007/s12020-017-1484-1

Table 1.

Clinico-pathologic characteristics of patients with unifocal papillary microcarcinoma, noninvasive encapsulated follicular variant (mPTC, NI-EFV) included in the study

All patients (n = 52)
Gender Female 45 87%
Male 7 13%
Age, median (range) 52 (27 – 81)
Clinical presentation Incidental finding 39 75%
Non-incidental 13 25%
Size, cm, median of all tumors (range) 0.44 (0.1 – 0.9)
Size of non-incidental tumor, cm, median (range) 0.7 (0.4 – 0.9)
Sampling of the thyroid gland Entirely sampled 23 44%
Representatively Sampled 29 56%
Sections of thyroid sampled, mean, median (range) 12, 10 (2 – 26)
Sampling and status of lymph nodes pNx: Not sampled 32 62%
pN0: Benign lymph node(s) N0 20 38%
Surgical procedure Lobectomy 23 44%
Total thyroidectomy 29 56%
Encapsulation Encapsulated 22 42%
Well circumscribed 30 58%
Other benign tumors Adenoma 9 17%
None 45 83%
Follow up duration, years, median (range) 4.3 (1.0–18.1)
Disease status at last follow up (FU) No evidence of disease (NED) 52 100%
Patients with at least 2 year follow up (n = 38)
Surgical procedure Lobectomy/hemithyroidectomy 15 39%
Total thyroidectomy 23 61%
Follow up duration, years, median (range) 6.3 (2.0 –18.1)
Disease status at last FU NED 38 100%
Patients with at least 5 year follow up (n = 25)
Surgical procedure Lobectomy 12 48%
Total/subtotal thyroidectomy 13 52%
Follow up duration, years, median (range) 9.6 (5.2–18.1)
Disease status at last FU NED 25 100%
a

All values are expressed as N and % of column total unless otherwise specified.